Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-23 4:20 pm Sale | 2024-08-22 | 13G | NewAmsterdam Pharma Company N.V. NAMS | AMGEN INC AMGN | 0 0.000% | -4,910,000 (Position Closed) | Filing History |
| 2024-02-13 4:58 pm Purchase | 2023-12-29 | 13G | Amgen Inc. AMGN | The Vanguard Group | 49,036,311 9.160% | 971,172 (+2.02%) | Filing History |
| 2024-01-30 11:35 am Sale | 2023-12-31 | 13G | Amgen Inc. AMGN | STATE STREET CORP STT | 29,543,705 5.520% | -216,383 (-0.73%) | Filing History |
| 2024-01-25 1:48 pm Sale | 2023-12-31 | 13G | Amgen Inc. AMGN | BlackRock Inc. BLK | 47,811,356 8.900% | -701,723 (-1.45%) | Filing History |
| 2023-09-27 07:30 am Purchase | 2023-09-19 | 13D | Neumora Therapeutics, Inc. Common Stock NMRA | AMGEN INC AMGN | 35,368,653 23.200% | 35,368,653 (New Position) | Filing History |
| 2023-02-10 4:18 pm Sale | 2023-01-31 | 13G | Jasper Therapeutics, Inc. JSPR | AMGEN INC AMGN | 100,993 0.900% | -169,007 (-62.60%) | Filing History |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Amgen Inc. AMGN | The Vanguard Group | 48,065,139 9.010% | 1,404,130 (+3.01%) | Filing History |
| 2023-02-07 2:10 pm Sale | 2022-12-31 | 13G | Amgen Inc. AMGN | BlackRock Inc. BLK | 48,513,079 9.100% | -1,533,266 (-3.06%) | Filing History |
| 2023-02-06 08:59 am Sale | 2022-12-31 | 13G | Amgen Inc. AMGN | STATE STREET CORP STT | 29,760,088 5.580% | -461,620 (-1.53%) | Filing History |
| 2022-12-02 06:01 am Purchase | 2022-11-22 | 13G | NewAmsterdam Pharma Company N.V. NAMS | AMGEN INC AMGN | 4,910,000 6.000% | 4,910,000 (New Position) | Filing History |
| 2022-02-11 12:22 pm Sale | 2022-02-14 | 13G | Amgen Inc. AMGN | Capital Research Global Investors | 22,157,906 3.900% | -9,604,421 (-30.24%) | Filing History |
| 2022-02-10 2:17 pm Purchase | 2021-12-31 | 13G | Amgen Inc. AMGN | STATE STREET CORP STT | 30,221,708 5.370% | 108,424 (+0.36%) | Filing History |
| 2022-02-09 3:24 pm Sale | 2021-12-31 | 13G | Amgen Inc. AMGN | The Vanguard Group | 46,661,009 8.280% | -566,220 (-1.20%) | Filing History |
| 2022-01-31 5:59 pm Purchase | 2021-12-31 | 13G | Amgen Inc. AMGN | BlackRock Inc. BLK | 50,046,345 8.900% | 2,240,551 (+4.69%) | Filing History |
| 2022-01-11 9:33 pm Purchase | 2022-01-11 | 13G | Vigil Neuroscience, Inc. VIGL | AMGEN INC AMGN | 3,206,281 11.300% | 3,206,281 (New Position) | Filing History |
| 2021-10-01 5:27 pm Purchase | 2021-09-24 | 13G | Jasper Therapeutics, Inc. JSPR | AMGEN INC AMGN | 270,000 7.400% | 270,000 (New Position) | Filing History |
| 2021-02-16 3:46 pm Sale | 2021-02-16 | 13G | Amgen Inc. AMGN | Capital Research Global Investors | 31,762,327 5.500% | -3,575,312 (-10.12%) | Filing History |
| 2021-02-10 10:30 am Sale | 2020-12-31 | 13G | Amgen Inc. AMGN | The Vanguard Group | 47,227,229 8.110% | -1,244,296 (-2.57%) | Filing History |
| 2021-02-05 4:35 pm Sale | 2020-12-31 | 13G | Akero Therapeutics, Inc. AKRO | AMGEN INC AMGN | 1,508,375 4.344% | -397,323 (-20.85%) | Filing History |
| 2021-02-05 4:31 pm Unchanged | 2020-12-31 | 13G | Provention Bio, Inc. PRVB | AMGEN INC AMGN | 2,500,000 4.426% | 0 (Unchanged) | Filing History |